Indraprastha Medical Corporation Share Price

NSE
INDRAMEDCO •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Indraprastha Medical Corporation Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
209.39% Gain from 52W Low
4.2
TTM PE Ratio
Below industry Median
29.7
Price to Book Ratio
Above industry Median
9.2
Dividend yield 1yr %
Above industry Median
0.9
TTM PEG Ratio
PEG TTM is less than 1
0.7

Indraprastha Medical Corporation Ltd shareholding Pattern

Promoter
51%
Foreign Institutions
2.6%
Mutual Funds
2.7%
Domestic Institutions
3.2%
Public
43.2%
Promoter
51%
Foreign Institutions
1.7%
Mutual Funds
2.6%
Domestic Institutions
3.1%
Public
44.1%
Promoter
51%
Foreign Institutions
1.1%
Domestic Institutions
4.9%
Public
43%
Promoter
51%
Foreign Institutions
1%
Domestic Institutions
6.3%
Public
41.7%
Promoter
51%
Foreign Institutions
0.8%
Domestic Institutions
6.7%
Public
41.5%
Promoter
51%
Foreign Institutions
0.4%
Public
48.6%

Indraprastha Medical Corporation Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
496.60
10Day EMA
494.00
12Day EMA
491.90
20Day EMA
482.30
26Day EMA
475.80
50Day EMA
455.00
100Day EMA
414.80
200Day EMA
350.40
5Day SMA
500.20
10Day SMA
498.00
20Day SMA
482.10
30Day SMA
465.60
50Day SMA
449.00
100Day SMA
421.00
150Day SMA
362.80
200Day SMA
326.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
107369 Rs
216342 Rs
Week Rs
130489 Rs
303535 Rs
Month Rs
154597 Rs
365142 Rs
Resistance & Support
494.27
Pivot
Resistance
First Resistance
502.58
Second Resistance
514.87
Third Resistance
523.18
Support
First Support
481.98
Second support
473.67
Third Support
461.38
Relative Strength Index
56.50
Money Flow Index
61.81
MACD
16.04
MACD Signal
17.03
Average True Range
21.50
Average Directional Index
21.46
Rate of Change (21)
17.89
Rate of Change (125)
96.87

Indraprastha Medical Corporation Ltd Company background

Founded in: 1988
Managing director: P Shivakumar
Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988. The main business of the Company is to enhance the quality of life of patients by providing comprehensive, highquality hospital services on a costeffective basis.The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000. IMCL is setting up a multidisciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex, Mahatma Gandhi Marg, New Delhi. The Companys efforts culminated on 18 September 1983, when Indias first corporate hospital, Apollo Hospitals in Madras, came into existence. In 199899, stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy.During 19992000, the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tieups with private air transport companies to transfer critical cases.A Puva UV therapy unit, for treatment of complex skin conditions, has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital, providing out door consultations and diagnostic facilities, was opened in Feb.2001, in Delhi. This clinic also functions as a referral and sample collection centre for laboratory investigation.A high energy linear accelerator was installed with multileaf collimeter enabling selective radiation to the affected part sparing normal tissue. A four digit telephone number 1066 was introduced by the Hospital for Emergency Medical Services and this is the first of its kind in the country. Three more super specialites namely Joint replacement,Spinal disorders and vascular surgeries have been started in the Hospital. The HIS is nearing completion and will be fully operational in the fag end of this financial year.During October 2001 the Hospital opened the Satellite Clinic at Golf Link,New Delhi.The new 57bed Apollo Hospital in Noida offering secondary and tertiary services became operational in 2006. A specialized Clinic for Chest Pain under the banner Apollo Chest Pain Centre (ACPC) was launched in three locations, Bansal Hospital in Friends Colony, Sehgal Nursing Home in Paschim Vihar and the Apollo Clinic in Vasant Kunj, New Delhi.During 200910, Indraprastha Apollo Hospitals introduced Endoscopic Ultra Sonology (EUS), a major advancement in diagnosing and treating gastrointestinal and pancreatobiliary diseases. The Multi Organ Transplant unit of the Hospital performed 268 organ transplants in the financial year 200910 (117 liver and 151 kidney transplants). Significant renovation and upgradation work was completed during the year, which should add to patient comfort and help achieve more operational efficiencies. Among others, a new orthopaedics operation theatre, a 5bed ICU for critical cardiac care patients, a 12 bed Multi Organ Transplant Unit for Renal Transplant patients, a Mezzanine in the atrium for ICU patient attendants and international patient lounge were commissioned. 58 patient rooms and 3 OPDs were also renovated.A new Endoscopic Ultrasound Unit was commissioned in 201011. A Bone Marrow Transplant Unit, one of the highest end of medical services, was also created in the Hospital for intensive treatment and management of certain cancers like leukemia, lymphomas and also some noncancerous diseases like thalessaemia. A multi organ transplant unit was added to the increasing organ transplant demands. Renovated four OPD wings and day care facility. An OP pharmacy, OPD billing counter, Insurance TPA help desk and ICU patient lobby have been setup for the comfort and ease of patients.The expansion project undertaken by the Hospital was completed in 2011. In addition, a Cosmetic Centre was set up to provide aesthetic medicine on an outpatient basis. Out of the additional beds, 50 beds were commissioned. As part of the ongoing upgradation and renovation programme, a number of departments and units such as Gynecology Pediatric OPD, Sample collection Chemotherapeutics Admixture Room Telemedicine Room Fetal Medicine Nucleic Acid Testing (NAT) Laboratory and Staff Cafeteria were refurbished to increase patient comfort and enhance operational efficiency. In order to meet the pressing demand of Dialysis and increased number of renal transplants, seven additional beds were commissioned in the Dialysis unit taking the capacity to 28. A new Out Patient Wing (OPD 2C) with 14 Consultation rooms was commissioned in place of 28 general ward beds, to accommodate the new Consultants.The Expansion Project undertaken by the main Hospital to add 127 additional Beds comprising of 74 single rooms, 33 general ward beds and 20 ICU beds, was completed. With the completion of the expansion project, the total bed strength of the Hospital has increased to 710 beds in 201213. The Apollo Institute of Robotic Surgery was launched in June, 2012 and has been performing a good number of robotic surgeries with the DaVinci Robotic Surgical System. The Hospital commissioned the Cosmetic Clinic in 2012.In 201314, the Apollo Obesity and Metabolic Surgery (Bariatric surgery) Centre was commissioned. The Apollo Institute of Robotic Surgery, which was instituted last year, performed 173 surgeries during the year. The Renal Transplant services were commenced in September, 2013 and resulting to this, a total of 18 transplants were conducted in the Noida hospital during the year. The Pain Clinic was started in January 2014 offering integrated and comprehensive Pain Management for all kinds of pain. Given the rising burden of NonCommunicable Diseases and Diabetes, the Sugar Clinic was also started to help patients in better management of Diabetes and prevention of associated complications. The hospital also expanded its Emergency department with 10 additional beds being added along with a complete renovation. The total strength of the unit stands at 20 beds. Also, the Urology, Nephrology and Dermatology OP areas underwent renovation. A large number of equipments were replaced or upgraded in various specialities including Oncology, Fetal Medicine, Cosmetics, Cardiology and Microbiology along with OT and other equipment at the main hospital and in Noida.Project Priceless, an Apollo wide initiative supported by inputs from Bain Company, to improve overall patient experience and improve patient and physician advocacy for the Hospital, commenced in June, 2014. Plastic and Cosmetic Surgery: New Antiaging procedures have been introduced such as Midface volumization Skin lifting and tightening Ulthera procedure for face, upper neck, lower neck and arms and Cool Sculpting for noninvasive localized fat reduction for body contouring. In addition, a multitude of new investigation services have been started including Chromosomal Genetic Study, Contrast Enhanced Ultrasonography, etc. Various new Diagnostic or Surgical processes have also been added in different specialties such as Clot Evacuation in Urology, Tracheal or Bronchial Stent placement in Respiratory medicine, FET PET MRI for better imaging of brain tumours, Molecular Imaging, Nuclear Medicine, etc.The Central Asia eNetwork link was launched on 12th July 2015. The event featured a teleconsultation for a cardiac patient between doctors in Osh city in Southern Kyrgyzstan, in Bishkek and with Apollo Hospital and AIIMS. The Hospital completed a successful cadaver split liver transplant wherein both the parts of the liver were given to two adult recipients. This was the first split liver transplant in two adults reported in the city and the second in India.Indraprastha Apollo Hospitals started providing Geriatric Services starting December 2016. New technique of Molecular Micro Film Array (Biofire) for rapid detection of microorganisms in cases of meningitis/ encephalitis, sepsis, respiratory infections and gastroenteritis were introduced in Molecular Microbiology. In 201819, the Hospital commissioned a new stateoftheart Chemotherapy Unit with 30 beds.During 202122, the Bone Marrow Transplant (BMT) project Unit, created a dedicated wing for BMT unit with 8 single rooms, 3 general ward beds and 1 procedure room, which was commissioned in August 2021. Bronchoscopy and PFT lab were cohorted in one area to make it manpower optimal. A 25bedded Dialysis Unit was created in the Lower Basement of the hospital to create a better patient experience. Orthopaedic operating theatre was moved from Ground Floor to the first floor so that all theatres are cohorted in one area. The Radiology Unit was renovated to improve patient experience.The financial year 202223 was a year of reset for both, the clinical services, and the infrastructure. The hospital introduced a slew of differentiated clinical programmes including Structural Heart Diseases, minimally invasive and Robotic Cardiac Surgeries, Leadless pacemakers, Cardiodiagnostics like Cardiac MRI and niche Gastroenterological procedures like Third space endoscopy. Multiple cases of Total Hip replacements and many cases of complicated congenital heart diseases were carried out successfully by our team of doctors. A 71yearoldmale, diagnosed as a case of localized adenocarcinoma prostate, underwent a successful nerve sparing robotic radical prostatectomy with amniotic nerve wrap with bilateral pelvic lymph node dissection. A 61yearold female patient successfully underwent a transcatheter mitral valve replacement (TMVR). A 64yearold male from Fiji underwent Robotic assisted total arterial triple vessel coronary artery bypass surgery. A 28yearold young man from Oman was treated successfully for a deformity in his left knee using 3D printing technology. A 21yearold male underwent a successful Robot assisted TransOral surgery to remove a large parapharyngeal space tumour (tumour in the deep tissues of the neck, nerves, lymph nodes, and parts of salivary gland). A total hip arthroplasty was successfully performed on a 50yearold. The patient was suffering with an extremely rare condition of Primary Synovial chondromatosis of the Hip. Several new equipment were added to hospitals arsenal. The most significant investment was the ZAPX Gyroscopic Radiosurgery system. To accommodate the increasing number of clinical services and to better patient experience, the hospital undertook a series of transformative infrastructural revamp projects including cohorting all operating theatres, creating a cohorted endoscopy suite, new dialysis suite, new international patient lounge and new Oncology OPD. A biomethanation plant was set up with a capacity of 1 Ton to enable inhouse treatment of Food, Kitchen, and Biomass waste and convert the waste into Biogas and Organic Manure.In 2024, Company performed more than 30 robotic cardiac surgeries, with zero mortality and it is working towards making Aortic surgeries easily accessible for the affected segment. A 70yearold Australian woman with possible recurrence of ovarian/fallopian tube cancer, initially treated in 2015, underwent a laparoscopic excision of the recurrent tumor and umbilical nodule followed by dendritic cell therapy (DCT). The first robotic hip replacement using the direct anterior approach (bikini incision hip replacement) was performed for the first time in North India. An ascending aorta and aortic arch replacement with frozen elephant trunk was performed in a 58yearold Kenyan patient with an ascending aorta aneurysm with dilated aortic arch and ulcer in proximal descending aorta. All the arch branches were reimplanted onto the prosthetic graft. The part of the procedure was done on total circulatory arrest using a special hybrid graft Thoraflex. The first supine PCNL for renal stones is an evolutionary change in procedure and was performed for the first time in Apollo Delhi. A multidisciplinary team, including Physicists, Neurosurgeons, ENT specialists, and Oncologists, successfully treated over 30 patients with various conditions using Stereotactic Gyroscopic Radiosurgery (ZapX) for the first time in South Asia, with ongoing active followup. Successful Reverse Shoulder Replacement for Neglected Proximal Humerus Fracture was a challenging case as there was severe osteoporosis with proximal humeral bone loss and atrophied shoulder girdle musculature.
Read More

Indraprastha Medical Corporation Ltd FAQs

Indraprastha Medical Corporation Ltd shares are currently priced at 478 on NSE and 480 on BSE as of 12/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Indraprastha Medical Corporation Ltd [INDRAMEDCO] share was 166.22. The Indraprastha Medical Corporation Ltd [INDRAMEDCO] share hit a 1-year low of Rs. 154.5 and a 1-year high of Rs. 529.9.

The market cap of Indraprastha Medical Corporation Ltd is Rs. 4494.58 Cr. as of 12/20/2024 12:00:00 AM.

The PE ratios of Indraprastha Medical Corporation Ltd is 30.35 as of 12/20/2024 12:00:00 AM.

The PB ratios of Indraprastha Medical Corporation Ltd is 8.55 as of 12/20/2024 12:00:00 AM

The Mutual Fund Shareholding was 2.66% at the end of 12/20/2024 12:00:00 AM.

You can easily buy Indraprastha Medical Corporation Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -